{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:16:34Z","timestamp":1789179394894,"version":"build-2803163510"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejpn.2025.02.008","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:34:32Z","timestamp":1740483272000},"page":"18-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inherited disorders of vitamin metabolism"],"prefix":"10.1016","volume":"55","author":[{"given":"Barbara","family":"Plecko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2025.02.008_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/clinchem\/43.4.680","article-title":"Vitamine-vitamin. The early years of discovery","volume":"43","author":"Rosenfeld","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejpn.2025.02.008_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11910-019-1011-2","article-title":"Neurology of nutritional deficiencies","volume":"19","author":"Miller","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ejpn.2025.02.008_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.2003.045963","article-title":"Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy","volume":"90","author":"Wang","year":"2005","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jimd.12125","article-title":"Genetic defects of thiamine transport and metabolism: a review of clinical phenotypes, genetics, and functional studies","volume":"42","author":"Marc\u00e9-Grau","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.02.008_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40261-021-01038-1","article-title":"Riboflavin in neurological diseases: a narrative review","volume":"41","author":"Plantone","year":"2021","journal-title":"Clin. Drug. Invest."},{"issue":"6","key":"10.1016\/j.ejpn.2025.02.008_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jimd.12541","article-title":"J Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency","volume":"45","author":"Van Bergen","year":"2022","journal-title":"Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jimd.12060","article-title":"Disorders affecting vitamin B6 metabolism","volume":"42","author":"Wilson","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib8","series-title":"GeneReviews\u00ae [Internet]","article-title":"PNPO deficiency","author":"Plecko","year":"1993"},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.63001","article-title":"Elevated homocysteine levels: what inborn errors of metabolism might we be missing?","volume":"191","author":"Gonzalez","year":"2023","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/jimd.12012","article-title":"The clinical presentation of cobalamin-related disorders: from acquired deficiencies to inborn errors of absorption and intracellular pathways","volume":"42","author":"Huemer","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib11","unstructured":"Zschocke J, Hoffmann G. In: Vademecum Metabolicum. Diagnosis and Treatment of Inherited Metabolic Disorders. Thieme Stuttgart, New York, Delhi, Rio de Janeiro. ISBN 978-3-13-243551-3."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10545-014-9712-9","article-title":"Defects of thiamine transport and metabolism","volume":"37","author":"Brown","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/bcmd.2000.0356","article-title":"Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport","volume":"27","author":"Neufeld","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/431216","article-title":"Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3","volume":"77","author":"Zeng","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejpn.2025.02.008_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1750-1172-9-92","article-title":"Thiamine transporter-2 deficiency: outcome and treatment monitoring","volume":"9","author":"Ortigoza-Escobar","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"8","author":"Alfadhel","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","article-title":"Biotin-responsive basal ganglia disease: a novel entity","volume":"121","author":"Ozand","year":"1998","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ejpn.2025.02.008_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejpn.2015.05.008","article-title":"Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone","volume":"19","author":"Tabarki","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajmg.10529","article-title":"Amish lethal microcephaly: a new metabolic disorder with severe congenital microcephaly and 2-ketoglutaric aciduria","volume":"112","author":"Kelley","year":"2002","journal-title":"Am. J. Med. Genet."},{"issue":"7","key":"10.1016\/j.ejpn.2025.02.008_bib20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ajmg.a.33373","article-title":"Amish microcephaly: long-term survival and biochemical characterization","volume":"152A","author":"Siu","year":"2010","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2025.02.008_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.21752","article-title":"SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis","volume":"66","author":"Spiegel","year":"2009","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2014.09.010","article-title":"Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations","volume":"113","author":"Banka","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ejpn.2025.02.008_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ajhg.2010.02.006","article-title":"Brown-Vialetto-Van Laere syndrome, a ponto- bulbar palsy with deafness, is caused by mutations in c20orf54","volume":"86","author":"Green","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajhg.2010.05.021","article-title":"Exome sequencing in Brown-Vialetto- van Laere syndrome","volume":"87","author":"Johnson","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"Pt 9","key":"10.1016\/j.ejpn.2025.02.008_bib25","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1093\/brain\/aws161","article-title":"Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease","volume":"135","author":"Johnson","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ejpn.2025.02.008_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10545-012-9513-y","article-title":"Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome","volume":"35","author":"Haack","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-7-83","article-title":"The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives","volume":"7","author":"Bosch","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"Pt 1","key":"10.1016\/j.ejpn.2025.02.008_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2025.02.008_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2018.10.017","article-title":"Oral therapy for riboflavin transporter deficiency - what is the regimen of choice?","volume":"61","author":"Gorcenco","year":"2019","journal-title":"Parkinsonism. Relat. Disord."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2022.04.003","article-title":"NAXE deficiency: a neurometabolic disorder of NAD(P)HX repair amenable for metabolic correction","volume":"136","author":"Manor","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejpn.2025.02.008_bib31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng1406","article-title":"Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19","volume":"36","author":"Seow","year":"2004","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ejpn.2025.02.008_bib32","first-page":"839","article-title":"On pathways and blind alleys-The importance of biomarkers in vitamin B6 -dependent epilepsies Inherit","volume":"46","author":"Plecko","year":"2023","journal-title":"Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib33","first-page":"79","article-title":"Seizures due to a KCNQ2 mutation: treatment with vitamin B6","volume":"27","author":"Reid","year":"2015","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ejpn.2025.02.008_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2025.02.008_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","article-title":"Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up","volume":"104","author":"Stockler","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0037-1621721","article-title":"Antiquitin deficiency with adolescent onset epilepsy: molecular diagnosis in a mother of affected offsprings","volume":"49","author":"Srinivasaraghavan","year":"2018","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib37","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/epi.16408","article-title":"Diagnosis of pyridoxine-dependent epilepsy in an adult presenting with recurrent status epilepticus","volume":"61","author":"Osman","year":"2020","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.ejpn.2025.02.008_bib38","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/j.1469-8749.2010.03660.x","article-title":"Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine- dependent epilepsy and pyridoxine phosphate oxidase deficiency","volume":"52","author":"Schmitt","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2025.02.008_bib39","unstructured":"Gospe SM jr. Pyridoxine Dependent Epilepsy-Aldh7a1. In: Margaret P Adam, Jerry Feldman, Ghayda M Mirzaa, Roberta A Pagon, Stephanie E Wallace, Lora JH Bean, Karen W Gripp, Anne Amemiya, editors. GeneReviews\u00ae [Internet]."},{"issue":"5","key":"10.1016\/j.ejpn.2025.02.008_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.21568","article-title":"Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy","volume":"65","author":"Gallagher","year":"2009","journal-title":"Ann. Neurol."},{"issue":"Pt 7","key":"10.1016\/j.ejpn.2025.02.008_bib41","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and Phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2025.02.008_bib42","article-title":"Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: a Dutch pilot study exploring clinical and patient-reported outcomes","volume":"31","author":"Tseng","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/humu.20433","article-title":"Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene","volume":"28","author":"Plecko","year":"2007","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.ejpn.2025.02.008_bib44","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-1094","article-title":"Pyridoxine-dependent epilepsy with elevated urinary \u03b1-amino adipic semialdehyde in molybdenum cofactor deficiency","volume":"130","author":"Struys","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jimd.12045","article-title":"The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy","volume":"42","author":"Coughlin","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jimd.12332","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","volume":"44","author":"Coughlin","year":"2021","journal-title":"Inherit. Metab. Dis."},{"issue":"23","key":"10.1016\/j.ejpn.2025.02.008_bib47","doi-asserted-by":"crossref","first-page":"e2627","DOI":"10.1212\/WNL.0000000000201222","article-title":"Association between lysine reduction therapies and cognitive outcomes in patients with pyridoxine-dependent epilepsy","volume":"99","author":"Coughlin","year":"2022","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ejpn.2025.02.008_bib48","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/hmg\/ddi120","article-title":"Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 50-phosphate oxidase","volume":"14","author":"Mills","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejpn.2025.02.008_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/cge.13843","article-title":"Phenotypic and molecular spectrum of pyridoxamine-5'-phosphate oxidase deficiency: a scoping review of 87 cases of pyridoxamine-5'-phosphate oxidase deficiency","volume":"99","author":"Alghamdi","year":"2021","journal-title":"Clin. Genet."},{"issue":"Pt 5","key":"10.1016\/j.ejpn.2025.02.008_bib50","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awu051","article-title":"Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome","volume":"137","author":"Mills","year":"2014","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.ejpn.2025.02.008_bib51","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0000000000000344","article-title":"Pyridoxine responsiveness in novel mutations of the PNPO gene","volume":"82","author":"Plecko","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2025.02.008_bib52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/dmcn.12346","article-title":"Typical and atypical phenotypes of PNPO deficiency with elevated CSF and plasma pyridoxamine on treatment","volume":"56","author":"Ware","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib53","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/jphp.12701","article-title":"Quality and stability of extemporaneous pyridoxal phosphate preparations used in the treatment of paediatric epilepsy","volume":"69","author":"Mohamed-Ahmed","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpn.2025.02.008_bib54","first-page":"67","article-title":"Cirrhosis associated with pyridoxal 5'- phosphate treatment of pyridoxamine 5'-phosphate oxidase deficiency","volume":"17","author":"Sudarsanam","year":"2014","journal-title":"JIMD. Rep."},{"issue":"5","key":"10.1016\/j.ejpn.2025.02.008_bib55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10545-016-9955-8","article-title":"The value of plasma vitamin B6 profiles in early onset epileptic encephalopathies","volume":"39","author":"Mathis","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"17","key":"10.1016\/j.ejpn.2025.02.008_bib56","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1021\/acs.analchem.7b01358","article-title":"An LC-MS\/MS-Based method for the quantification of pyridox(am)ine 5'-phosphate oxidase activity in dried blood spots from patients with epilepsy","volume":"89","author":"Wilson","year":"2017","journal-title":"Anal. Chem."},{"issue":"6","key":"10.1016\/j.ejpn.2025.02.008_bib57","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ajhg.2016.10.011","article-title":"Mutations in PROSC disrupt cellular pyridoxal phosphate homeostasis and cause vitamin-B(6)-dependent epilepsy","volume":"99","author":"Darin","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2025.02.008_bib58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/brain\/awy346","article-title":"PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights","volume":"142","author":"Johnstone","year":"2019","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.ejpn.2025.02.008_bib59","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/jmedgenet-2017-104521","article-title":"Confirmation of mutations in PROSC as a novel cause of vitamin B (6) -dependent epilepsy","volume":"54","author":"Plecko","year":"2017","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib60","first-page":"1","article-title":"Diagnostic pitfalls in vitamin B6-dependent epilepsy caused by mutations in the PLPBP gene","volume":"50","author":"Jensen","year":"2019","journal-title":"JIMD. Rep."},{"issue":"3","key":"10.1016\/j.ejpn.2025.02.008_bib61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/adc.82.3.236","article-title":"Fits, pyridoxine, and hyperprolinaemia type II","volume":"82","author":"Walker","year":"2000","journal-title":"Arch. Dis. Child."},{"issue":"18","key":"10.1016\/j.ejpn.2025.02.008_bib62","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1074\/jbc.M010860200","article-title":"Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II","volume":"276","author":"Farrant","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 3","key":"10.1016\/j.ejpn.2025.02.008_bib63","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s10545-009-9012-y","article-title":"Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5'-phosphate availability","volume":"33","author":"Balasubramaniam","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9\u201310","key":"10.1016\/j.ejpn.2025.02.008_bib64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000520341","article-title":"Lethal encephalopathy in an infant with hypophosphatasia despite enzyme replacement therapy","volume":"94","author":"Raimann","year":"2021","journal-title":"Horm. Res. Paediatr."},{"issue":"11","key":"10.1016\/j.ejpn.2025.02.008_bib65","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10072-014-1902-6","article-title":"Pyridoxine-induced sensory ataxic neuronopathy and neuropathy: revisited","volume":"35","author":"Kulkantrakorn","year":"2014","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajmg.c.30288","article-title":"Inborn errors of cobalamin absorption and metabolism","volume":"157C","author":"Watkins","year":"2011","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib67","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jimd.12009","article-title":"Vitamin B12 , folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation","volume":"42","author":"Froese","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ejpn.2025.02.008_bib68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-014-9687-6","article-title":"Clinical presentation and outcome in a series of 88 patients with the cblC defect","volume":"37","author":"Fischer","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-0032-1306389","article-title":"Leukoencephalopathies associated with disorders of cobalamin and folate metabolism","volume":"32","author":"Wilcken","year":"2012","journal-title":"Semin. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","article-title":"J Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer","year":"2017","journal-title":"Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/molecules28010240","article-title":"Vitamin B12 in foods, food supplements, and medicines - a review of its role and properties with a focus on its stability","volume":"28","author":"Raku\u0161a","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejpn.2025.02.008_bib72","first-page":"42","article-title":"Comparative bioavailability and utilization of particular forms of B12 supplements with potential to mitigate B12-related genetic polymorphisms. Integr","volume":"16","author":"Paul","year":"2017","journal-title":"Med"},{"issue":"Suppl. 2","key":"10.1016\/j.ejpn.2025.02.008_bib73","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/PL00014307","article-title":"Remethylation defects: guidelines for clinical diagnosis and treatment","volume":"157","author":"Ogier de Baulny","year":"1998","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10545-010-9120-8","article-title":"Isolated remethylation disorders: do our treatments benefit patients?","volume":"34","author":"Schiff","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.02.008_bib75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10545-008-0839-4","article-title":"Causes of and diagnostic approach to methylmalonic acidurias","volume":"31","author":"Fowler","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng0295-141","article-title":"Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein","volume":"9","author":"Ouahchi","year":"1995","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0022-3476(99)70424-5","article-title":"Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency","volume":"134","author":"Schuelke","year":"1999","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00228-009-0729-1","article-title":"Dosage and formulation issues: oral vitamin E therapy in children","volume":"66","author":"Westergren","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejpn.2025.02.008_bib79","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/17446651.3.6.715","article-title":"Biotin and biotinidase deficiency","volume":"3","author":"Zempleni","year":"2008","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107560","article-title":"Biotinidase deficiency: what have we learned in forty years?","volume":"138","author":"Tankeu","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ejpn.2025.02.008_bib81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2011.6","article-title":"Biotinidase deficiency: \u201cif you have to have an inherited metabolic disease, this is the one to have\u201d","volume":"14","author":"Wolf","year":"2012","journal-title":"Genet. Med."},{"issue":"7","key":"10.1016\/j.ejpn.2025.02.008_bib82","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(14)70110-3","article-title":"Occasional seizures, epilepsy, and inborn errors of metabolism","volume":"13","author":"Dulac","year":"2014","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2025.02.008_bib83","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00247-008-0904-z","article-title":"Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients","volume":"38","author":"Desai","year":"2008","journal-title":"Pediatr. Radiol."},{"issue":"12","key":"10.1016\/j.ejpn.2025.02.008_bib84","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1177\/1352458515596457","article-title":"Biotinidase deficiency mimicking neuromyelitis optica: initially exhibiting symptoms in adulthood","volume":"21","author":"Bottin","year":"2015","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2010.01.003","article-title":"Clinical issues and frequent questions about biotinidase deficiency","volume":"100","author":"Wolf","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib86","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-02-077099","article-title":"The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption","volume":"110","author":"Zhao","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib87","first-page":"40","article-title":"Hereditary folate malabsorption. Child Neurology: Neurology","volume":"97","author":"Huddar","year":"2021"},{"issue":"7","key":"10.1016\/j.ejpn.2025.02.008_bib88","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1023\/A:1012905823879","article-title":"A family study of congenital malabsorption of folate","volume":"24","author":"Jebnoun","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib89","first-page":"7","article-title":"Role of intramuscular levofolinate administration in the treatment of hereditary folate malabsorption: report of three cases JIMD","volume":"39","author":"Manea","year":"2018","journal-title":"Rep"},{"issue":"3","key":"10.1016\/j.ejpn.2025.02.008_bib90","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","article-title":"Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism","volume":"85","author":"Steinfeld","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejpn.2025.02.008_bib91","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/ncomms3123","article-title":"Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma","volume":"4","author":"Grapp","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpn.2025.02.008_bib92","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/brain\/aws122","article-title":"Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency","volume":"135","author":"Grapp","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1684\/epd.2014.0629","article-title":"Sensory stimulus-sensitive drop attacks and basal ganglia calcification: new findings in a patient with FOLR1 deficiency","volume":"16","author":"Toelle","year":"2014","journal-title":"Epileptic Disord."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib94","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jimd.12092","article-title":"Cerebral folate deficiency: analytical tests and differential diagnosis","volume":"42","author":"Pope","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.02.008_bib95","series-title":"Vitamine Responsive Disorders","article-title":"In swaiman 6th edition. Swaiman KF, ashwal st, ferriero DM, schor NF, finkel RS, gropman AL, pearl PhL, shevel M. Chapter 67","author":"Plecko","year":"2017"},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib96","first-page":"387","article-title":"Folate receptor \u03b1 deficiency \u2013 myelin-sensitive MRI as a reliable biomarker to monitor efficacy and long-term outcome of a new therapeutic approach","volume":"47","author":"Dreha-Kulaczewskil","year":"2024","journal-title":"JIMD"},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib97","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajhg.2011.01.004","article-title":"Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency","volume":"88","author":"Banka","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib98","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajhg.2011.01.007","article-title":"Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease","volume":"88","author":"Cario","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jimd.12041","article-title":"EHOD consortium; Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry","volume":"42","author":"Huemer","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.02.008_bib100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10545-015-9860-6","article-title":"Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency","volume":"39","author":"Huemer","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ejpn.2025.02.008_bib101","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.braindev.2011.05.014","article-title":"Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy","volume":"33","author":"Prasad","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.ejpn.2025.02.008_bib102","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2014.116","article-title":"Severe methylenetetrahydrofolate reductase deficiency: clinical clues to a potentially treatable cause of adult-onset hereditary spastic paraplegia","author":"Lossos","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.02.008_bib103","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jimd.12504","article-title":"Influence of early identification and therapy on long-term outcomes in early-onset MTHFR deficiency","volume":"45","author":"Yverneau","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ejpn.2025.02.008_bib104","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jmedgenet-2011-100286","article-title":"Novel inborn error of folate metabolism: identification by exome capture and sequencing of mutations in the MTHFD1 gene in a single proband","volume":"48","author":"Watkins","year":"2011","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ejpn.2025.02.008_bib105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10545-015-9810-3","article-title":"Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment","volume":"38","author":"Burda","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2025.02.008_bib106","first-page":"118","article-title":"5,10-methenyltetrahydrofolate synthetase deficiency causes a neurometabolic disorder associated with microcephaly, epilepsy, and cerebral hypomyelination","volume":"125","author":"Lance","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejpn.2025.02.008_bib107","article-title":"A case of 5,10-methenyltetrahydrofolate synthetase deficiency due to biallelic null mutations with novel findings of elevated neopterin and macrocytic anemia","volume":"21","author":"Romero","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"9","key":"10.1016\/j.ejpn.2025.02.008_bib108","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.braindev.2022.05.008","article-title":"A female case of 5,10-methenyltetrahydrofolate synthetase deficiency with novel neuro-imaging abnormalities","volume":"44","author":"Cavusoglu","year":"2022","journal-title":"Brain Dev."},{"issue":"2","key":"10.1016\/j.ejpn.2025.02.008_bib109","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jmd2.12409","article-title":"J Blom HJ 5,10-methenyltetrahydrofolate synthetase deficiency: an extreme rare defect of folate metabolism in two Dutch siblings Case","volume":"65","author":"Liepina","year":"2024","journal-title":"Reports JIMD Rep"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825000169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825000169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:23:26Z","timestamp":1752575006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379825000169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":109,"alternative-id":["S1090379825000169"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.02.008","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inherited disorders of vitamin metabolism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}